The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

About
Science 37.

Science 37 is the industry pioneer, accelerating the development of new and innovative treatments that impact patient lives. We enable universal access to patients and providers for clinical trials, leading to faster enrollment, greater retention and a more representative patient population. 

Our Operating System™ is configurable to enable any study and is fused with our expansive networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.

Science 37 Puts the Patient First, Bringing Faster Enrollment, Greater Retention, and a World-Wide Representative Population to Clinical Trials.

Values.

Science 37 is intentionally focused on making the patient the first priority, breaking the barriers of the traditional model of clinical trials, and making a real difference in patients’ lives. By developing groundbreaking treatments and creating new and innovative advancements, Science 37 is continually demonstrating our dedication to building a culture of gratitude and respect. 

Values.

Science 37 Leadership.

David Coman
David Coman
Chief Executive Officer
and Director
Elisa Cascade
Elisa Cascade
Chief Product Officer
Chris Ceppi
Chris Ceppi
Chief Technology Officer
Jonathan Cotliar
Jonathan Cotliar
Chief Medical Officer
Darcy Forman
Darcy Forman
Chief Delivery Officer
Drew Bustos
Drew Bustos
Chief Strategy and Marketing Officer
Steve Geffon
Steve Geffon
Chief Commercial Officer
Christine Pellizzari
Christine Pellizzari
Chief Legal Officer
Anita Modi
Anita Modi
VP, Business Transformation
Jim Young
Jim Young
Chief Human Resources Officer
Mike Zaranek
Mike Zaranek
Chief Financial Officer